Our long-term mission is to obtain detailed structural understandings of oncogenic proteins such as C-terminal Binding Protein (CtBP) and develop lead inhibitory compounds that disrupt their oncogenic activity to aid in the development of highly selective anti-neoplastic drugs.  

x

Research Areas

Commonly-Used Techniques

X-ray crystallography, biochemical and biophysical approaches.